AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paulsen, J. S.
Right arrow Articles by Rao, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paulsen, J. S.
Right arrow Articles by Rao, S. M.

BRAIN

fMRI Biomarker of Early Neuronal Dysfunction in Presymptomatic Huntington’s Disease

Jane S. Paulsena, Janice L. Zimbelmanb,c, Sean C. Hintonc, Douglas R. Langbehna, Catherine L. Leveronid, Michelle L. Benjamina, Norman C. Reynoldsc and Stephen M. Raoc

a Department of Psychiatry, University of Iowa College of Medicine, Iowa City
b Department of Health Sciences, Carroll College, Waukesha, WI
c Department of Neurology, Medical College of Wisconsin, Milwaukee
d Psychology Assessment Center, Massachusetts General Hospital, Boston

BACKGROUND AND PURPOSE: Functional MR imaging (fMRI) has been used to probe basal ganglia function in people with presymptomatic Huntington’s disease (pre-HD). A previous fMRI study in healthy individuals demonstrated activation of the basal ganglia during a time-discrimination task. The current study was designed to examine the relative sensitivity of fMRI compared with that of behavioral testing and morphometric measurements in detecting early neurodegenerative changes related to Huntington’s disease (HD).

METHODS: Pre-HD participants were assigned to two groups based on estimated years to diagnosis of manifest disease: close <12 years and far ≥12 years. Age at disease onset was estimated using a regression equation based on the number of trinucleotide CAG repeats. The time-discrimination task required participants to determine whether a specified interval was shorter or longer than a standard interval of 1200 milliseconds.

RESULTS: Participants in the close group performed more poorly on the time-task discrimination than did control subjects; however, no differences were observed between far participants and control subjects. Similarly, close participants had reduced bilateral caudate volume relative to that of control subjects, whereas far participants did not. On functional imaging, close participants had significantly less activation in subcortical regions (caudate, thalamus) than control subjects; far participants had an intermediate degree of activation. In contrast, far participants had hyperactivation in medial hemispheric structures (anterior cingulate, pre-supplementary motor area) relative to close and control subjects.

CONCLUSION: Hyperactivation of medial prefrontal regions compensated for reduced subcortical participation during time discrimination in pre-HD. This pattern of brain activation may represent an early neurobiologic marker of neuronal dysfunction.




This article has been cited by other articles:


Home page
Phil Trans R Soc BHome page
G. Koch, M. Oliveri, and C. Caltagirone
Neural networks engaged in milliseconds and seconds time processing: evidence from transcranial magnetic stimulation and patients with cortical or subcortical dysfunction
Phil Trans R Soc B, July 12, 2009; 364(1525): 1907 - 1918.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Beste, C. Saft, O. Gunturkun, and M. Falkenstein
Increased Cognitive Functioning in Symptomatic Huntington's Disease As Revealed by Behavioral and Event-Related Potential Indices of Auditory Sensory Memory and Attention
J. Neurosci., November 5, 2008; 28(45): 11695 - 11702.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
J. Brandt, A. B. Inscore, J. Ward, B. Shpritz, A. Rosenblatt, R. L. Margolis, and C. A. Ross
Neuropsychological Deficits in Huntington's Disease Gene Carriers and Correlates of Early "Conversion"
J Neuropsychiatry Clin Neurosci, November 1, 2008; 20(4): 466 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. G. Walker, B. R. Miller, J. N. Fritsch, S. J. Barton, and G. V. Rebec
Altered Information Processing in the Prefrontal Cortex of Huntington's Disease Mouse Models
J. Neurosci., September 3, 2008; 28(36): 8973 - 8982.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger, et al.
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 874 - 880.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. C. Wolf, N. Vasic, C. Schonfeldt-Lecuona, G. B. Landwehrmeyer, and D. Ecker
Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI
Brain, November 1, 2007; 130(11): 2845 - 2857.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Feigin, C. Tang, Y. Ma, P. Mattis, D. Zgaljardic, M. Guttman, J. S. Paulsen, V. Dhawan, and D. Eidelberg
Thalamic metabolism and symptom onset in preclinical Huntington's disease
Brain, November 1, 2007; 130(11): 2858 - 2867.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C. L Julien, J. C Thompson, S. Wild, P. Yardumian, J. S Snowden, G. Turner, and D. Craufurd
Psychiatric disorders in preclinical Huntington's disease
J. Neurol. Neurosurg. Psychiatry, September 1, 2007; 78(9): 939 - 943.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. A. Johnson, J. C. Stout, A. C. Solomon, D. R. Langbehn, E. H. Aylward, C. B. Cruce, C. A. Ross, M. Nance, E. Kayson, E. Julian-Baros, et al.
Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease
Brain, July 1, 2007; 130(7): 1732 - 1744.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D R Thiruvady, N Georgiou-Karistianis, G F Egan, S Ray, A Sritharan, M Farrow, A Churchyard, P Chua, J L Bradshaw, T-L Brawn, et al.
Functional connectivity of the prefrontal cortex in Huntington's disease
J. Neurol. Neurosurg. Psychiatry, February 1, 2007; 78(2): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. A. Bobholz, S. M. Rao, L. Lobeck, C. Elsinger, A. Gleason, J. Kanz, S. Durgerian, and E. Maas
fMRI study of episodic memory in relapsing-remitting MS: correlation with T2 lesion volume.
Neurology, November 14, 2006; 67(9): 1640 - 1645.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Blekher, S. A. Johnson, J. Marshall, K. White, S. Hui, M. Weaver, J. Gray, R. Yee, J. C. Stout, X. Beristain, et al.
Saccades in presymptomatic and early stages of Huntington disease
Neurology, August 8, 2006; 67(3): 394 - 399.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. Finke, P. Bublak, M. Dose, H. J. Muller, and W. X. Schneider
Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease
Brain, May 1, 2006; 129(5): 1137 - 1151.
[Abstract] [Full Text] [PDF]